Description
The Tumor Test Marker YRA385 // YRA391 is an advanced diagnostic tool essential for the early detection of cancer. Designed for precision, this highly efficient test kit works seamlessly with chemiluminescence immunoassay (CLIA) analyzers to detect an impressive array of 18 different tumor markers. With its powerful capability to identify elevated tumor marker levels in the blood, it plays a critical role in diagnosing and recognizing a variety of malignant tumors, providing valuable insights for clinicians and researchers alike.
Market Price
The Tumor Test Marker YRA385 // YRA391 is competitively priced, reflecting its high precision and reliability. On average, the market price for this type of tumor marker test kit ranges from $200 to $500, depending on the specific model and packaging options. We encourage potential buyers to explore our Kalstein Plus platform for a personalized quote that suits their budget and clinical needs.
Frequently Asked Questions
What is the purpose of the Tumor Test Marker YRA385 // YRA391?
The primary purpose of this test marker is to facilitate early cancer detection by identifying and measuring tumor markers in blood samples.
How many tests are provided in a single package?
The kits are available with various packaging specifications, including 50T/BOX, 100T/BOX, and 24T/BOX options, allowing flexibility based on usage requirements.
Advantages and Disadvantages
Advantages: The Tumor Test Marker YRA385 // YRA391 offers high accuracy and a wide range of testing parameters, making it a versatile option for comprehensive cancer screening. Its compatibility with CLIA analyzers ensures consistent and reliable results.
Disadvantages: The test kit requires specific equipment for chemiluminescence analysis, potentially limiting its use to facilities with compatible hardware.
Application in the Field
In practical settings, the Tumor Test Marker YRA385 // YRA391 is used in hospitals and research laboratories to conduct in-depth analyses of blood samples. Its capacity to identify multiple tumor markers in a single test makes it invaluable for ongoing cancer research and routine patient screenings.
Recommendations
To achieve the best results, it is recommended that users store the test kits at temperatures between 2-8°C. Regular calibration using the 2/6 point system ensures optimal performance and accuracy in test results. For a seamless purchasing experience and to learn more about our competitive pricing options, we invite you to request a quotation through our Kalstein Plus platform today.
Features
- Detection of 18 different tumor markers.
- Designed for chemiluminescence immunoassay (CLIA) analyzers.
- Available in multiple packaging specifications.
- CE, ISO13485, and FSC certifications indicating high standards of quality.
- Analysis using the alkaline phosphatase (AP) platform.
Technical Specifications
Model | YRA385 | YRA386 | YRA387 | YRA388 | YRA389 | YRA390 | YRA391 |
Tested Parameter | AFP | CEA | CA125 | CA15-3 | CA19-9 | f-PSA | t-PSA |
Analysis Mode | CLIA | ||||||
Package Specification | 50T/BOX, 100T/BOX,24T/BOX | ||||||
Platform | AP(Alkaline Phosphatase) | ||||||
Storage | 2-8°C | ||||||
Calibration | 2/6 Points | ||||||
Certification | CE, ISO13485,FSC |